Were hanging out talking Abbott pharma politics again. What is the scoop on this emerging company? To me they are fading fast. They need some FDA investigations to find out what is happening here.
What about the FDA problems? Cannot talk about the meetings last week. We have lots of stuff going with these guys again.
The bottom line is do we wait for the government to approve it as an antibiotic or do we go ahead right now and sell it as a furniture polish?
